nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2004-8-3-15-21nefr-845Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESЛЕГКАЯ ДИСФУНКЦИЯ ПОЧЕК У БОЛЬНЫХ С ЭССЕНЦИАЛЬНОЙ ГИПЕРТОНИЕЙ: КЛИНИЧЕСКИЕ ПРОЯВЛЕНИЯ И ЛЕКАРСТВЕННАЯ ТЕРАПИЯMILD RENAL DYSFUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION: CLINICAL SIGNS AND DRUG THERAPYКузьминО. Б.KuzminO. B.

Кафедра фармакологии

ПугаеваМ. О.PugaevaM. O.

Кафедра фармакологии

ЧубС. В.ChubS. V.

Кафедра фармакологии

Оренбургская государственная медицинская академияRussian Federation200410032004831521Copyright © Кузьмин О.Б., Пугаева М.О., Чуб С.В., 20042004Кузьмин О.Б., Пугаева М.О., Чуб С.В.Kuzmin O.B., Pugaeva M.O., Chub S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/845

Легкая дисфункция почек у больных с эссенциальной гипертонией: клинические проявления и лекарственная терапия.

Mild renal dysfunction in patients with essential hypertension: clinical signs and drug therapy.

эссенциальная гипертониялегкая дисфункция почекклинические проявлениялекарственная терапияessential hypertensionmild renal dysfunctionclinical signsdrug therapeuticsReferencesRuilope LM ,Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 2001; 12 (2): 218225Ruilope LM ,Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 2001; 12 (2): 218225Ruilope LM, Palmer C, de Leeuw P et al. Evaluation of different parameters of renal function as a predictors of primary outcome in the INSIGHT study. J Hypertens 2001; 12 [Suppl 2]: 223Ruilope LM, Palmer C, de Leeuw P et al. Evaluation of different parameters of renal function as a predictors of primary outcome in the INSIGHT study. J Hypertens 2001; 12 [Suppl 2]: 223Mann JFE, Gerstein HC, Poque J et al. Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: The HOPE randomization trial. Ann Intern Med 2001; 134 (8): 629636Mann JFE, Gerstein HC, Poque J et al. Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: The HOPE randomization trial. Ann Intern Med 2001; 134 (8): 629636Palatini P, Graniero GR, Mormino P et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from Hypertension and Ambulatory Recording Venetia Study (HARVEST). Am J Hypertens 1996; 9 (4): 334341Palatini P, Graniero GR, Mormino P et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from Hypertension and Ambulatory Recording Venetia Study (HARVEST). Am J Hypertens 1996; 9 (4): 334341Pontremoli R, Sofia A, Ravera M et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC Study. Microalbuminuria: A Genoa Investigation on Complication. Hypertension 1997; 30 (5): 11351143Pontremoli R, Sofia A, Ravera M et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC Study. Microalbuminuria: A Genoa Investigation on Complication. Hypertension 1997; 30 (5): 11351143Osicka TM, Comper WD. Protein degradation during renal passage in normal kidney is inhibited in experimental albuminuria. Clin Sci 1997; 93 (1): 6572Osicka TM, Comper WD. Protein degradation during renal passage in normal kidney is inhibited in experimental albuminuria. Clin Sci 1997; 93 (1): 6572Wachtell K, Olsen MH, Dahlof B et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hyperthrophy: the LIFE study. J Hypertens 2001; 20 (3): 353355Wachtell K, Olsen MH, Dahlof B et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hyperthrophy: the LIFE study. J Hypertens 2001; 20 (3): 353355Donelly R, Rea R. Microalbuminuria: how informative and reliable are individual measurements? J Hypertens 2003; 21 (7): 12291233Donelly R, Rea R. Microalbuminuria: how informative and reliable are individual measurements? J Hypertens 2003; 21 (7): 12291233Pontremoli R, Ravera M, Bezante GP et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17 (7): 9931000Pontremoli R, Ravera M, Bezante GP et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17 (7): 9931000Terpstra WF, May JF, Smit AJ et al. Microalbuminuria is related to marked end organ damage in previously untreated elderly hypertensive patients. Blood Press 2002; 11 (2): 8490Terpstra WF, May JF, Smit AJ et al. Microalbuminuria is related to marked end organ damage in previously untreated elderly hypertensive patients. Blood Press 2002; 11 (2): 8490Wachtell K, Palmieri V, Olsen MH et al. Urine albumin / creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143 (2): 319326Wachtell K, Palmieri V, Olsen MH et al. Urine albumin / creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143 (2): 319326Jensen JS, FeldtRasmussen B, Strandgaard S et al. Arterial hypertension, microalbuminuria and risk of ischemic heart desease. Hypertension 2000; 35 (4): 898903Jensen JS, FeldtRasmussen B, Strandgaard S et al. Arterial hypertension, microalbuminuria and risk of ischemic heart desease. Hypertension 2000; 35 (4): 898903Nakamura S, Kawano Y, Inenaga I et al. Microalbuminuria and cardiovascular events in elderly hypertensive patients without previous cardiovascular implications. Hypertens Res 2003; 26 (8): 603608Nakamura S, Kawano Y, Inenaga I et al. Microalbuminuria and cardiovascular events in elderly hypertensive patients without previous cardiovascular implications. Hypertens Res 2003; 26 (8): 603608Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139 (11): 901906Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139 (11): 901906Romundstadt S, Holmen J, Hallan H et al. Microalbuminuria and allcause mortality in treated hypertensive individuals: does sex matter? The NordTrondelag Health Study (HUNT), Norway. Circulation 2003; 108 (22): 2783 2789Romundstadt S, Holmen J, Hallan H et al. Microalbuminuria and allcause mortality in treated hypertensive individuals: does sex matter? The NordTrondelag Health Study (HUNT), Norway. Circulation 2003; 108 (22): 2783 2789Brown MJ, Palmer CR, Castaigne A et al. Morbidity and mortality in patients randomized to doubleblind treatment with longacting calciumchannel blocker or diuretic in International Nifidipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356 (9228): 366372Brown MJ, Palmer CR, Castaigne A et al. Morbidity and mortality in patients randomized to doubleblind treatment with longacting calciumchannel blocker or diuretic in International Nifidipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356 (9228): 366372Luque V, GarsiaRobles R, Tamargo J, Ruilope LM. Blood pressure control in hospital located hypertension units [Abstract]. Hypertension 2001; 37: 1030.Luque V, GarsiaRobles R, Tamargo J, Ruilope LM. Blood pressure control in hospital located hypertension units [Abstract]. Hypertension 2001; 37: 1030.Ruilope LM. The kidney as a sensor of cardiovascular risk in essential hypertension. J Am Soc Nephrol 2002; 13 [Suppl 3]: S165S168Ruilope LM. The kidney as a sensor of cardiovascular risk in essential hypertension. J Am Soc Nephrol 2002; 13 [Suppl 3]: S165S168Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 3141Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 3141VounierVehier C, Amah G, Duquenoy S et al. Is assessment of kidney involvement in patients with essential hypertension satisfactory? General medical observation results of national study (PHENOMEN). Arch Mal Coeur Vaiss 2003; 96 (78): 792 799VounierVehier C, Amah G, Duquenoy S et al. Is assessment of kidney involvement in patients with essential hypertension satisfactory? General medical observation results of national study (PHENOMEN). Arch Mal Coeur Vaiss 2003; 96 (78): 792 799Leoncini G, Viazzi F, Parodi D et al. Mild renal dysfunction and cardiovascular risk in hypertensive patients. J Am Soc Nephrol 2004; 15 [Suppl 1]: S88S90Leoncini G, Viazzi F, Parodi D et al. Mild renal dysfunction and cardiovascular risk in hypertensive patients. J Am Soc Nephrol 2004; 15 [Suppl 1]: S88S90de Leeuw PW, Thijs L, Birkenhager WH et al. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the SystEur Ttrial. J Am Soc Nephrol 2002; 13 (9): 22132222de Leeuw PW, Thijs L, Birkenhager WH et al. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the SystEur Ttrial. J Am Soc Nephrol 2002; 13 (9): 22132222Chobanian A, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42 (6): 12061252Chobanian A, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42 (6): 12061252Guidelines Committee. 2003 European Society of hypertension / European Society of cardiology guidelines for management of arterial hypertension. J Hypertens 2003; 21 (6): 10111053Guidelines Committee. 2003 European Society of hypertension / European Society of cardiology guidelines for management of arterial hypertension. J Hypertens 2003; 21 (6): 10111053Кузьмин ОБ, Пугаева МО. Дисфункция почки при хронической сердечной недостаточности: теоретические и клинические аспекты. Нефрология 2003; 7 (2): 3137Кузьмин ОБ, Пугаева МО. Дисфункция почки при хронической сердечной недостаточности: теоретические и клинические аспекты. Нефрология 2003; 7 (2): 3137Кузьмин ОБ. Дисфункция почек при сердечной не достаточности и ее лекарственная коррекция. Медицина, М., 2003; 152Кузьмин ОБ. Дисфункция почек при сердечной не достаточности и ее лекарственная коррекция. Медицина, М., 2003; 152Кузьмин ОБ, Пугаева МО. Нейрогуморальный дисбаланс как причина дисфункции почек при первичной артериальной гипертонии. Нефрология 2004; 8 (1): 1925Кузьмин ОБ, Пугаева МО. Нейрогуморальный дисбаланс как причина дисфункции почек при первичной артериальной гипертонии. Нефрология 2004; 8 (1): 1925Simons JL, Provoost AP, Anderson S et al. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994; 46 (3): 396404Simons JL, Provoost AP, Anderson S et al. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994; 46 (3): 396404Durvasula RV, Petermann AT, Hiromura K et al. Activation of local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 3039Durvasula RV, Petermann AT, Hiromura K et al. Activation of local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 3039Gruden G, Zonca S, Hayward A et al. Mechanical stretch induced fibronectin and TGFІ1 in human mesangial cells is p38 mitogenactivated protein kinase dependent. Diabetes 2000; 49 (4): 655661Gruden G, Zonca S, Hayward A et al. Mechanical stretch induced fibronectin and TGFІ1 in human mesangial cells is p38 mitogenactivated protein kinase dependent. Diabetes 2000; 49 (4): 655661Asselbergs FW, de Boer RA, Diercks GF et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Int J Cardiol 2004; 93 (23): 211215Asselbergs FW, de Boer RA, Diercks GF et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Int J Cardiol 2004; 93 (23): 211215Ciriello J, de Oliveira CV. Renal afferents and hypertension. Curr Hypertens Rep 2002; 4 (2): 136142Ciriello J, de Oliveira CV. Renal afferents and hypertension. Curr Hypertens Rep 2002; 4 (2): 136142Augustyniak RA, Tuncel M, Zhang W et al. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 2002; 20 (1): 39Augustyniak RA, Tuncel M, Zhang W et al. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 2002; 20 (1): 39Арутюнов ГП, Чернявская ТК, Лукичева ТИ. Микро альбуминурия: клинические аспекты и пути медикаментоз ной коррекции. Клин фарм тер 1999; 8 (3): 2328Арутюнов ГП, Чернявская ТК, Лукичева ТИ. Микро альбуминурия: клинические аспекты и пути медикаментоз ной коррекции. Клин фарм тер 1999; 8 (3): 2328Douglas J G, Agodoa L. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial. Kidney Int 2003; 83 (Suppl): S74S76Douglas J G, Agodoa L. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial. Kidney Int 2003; 83 (Suppl): S74S76Ruilope LM. New European guidelines for the management of hypertension: what is relevant for the nephrologists? Nephrol Dial Transplant 2004; 19 (3): 524528Ruilope LM. New European guidelines for the management of hypertension: what is relevant for the nephrologists? Nephrol Dial Transplant 2004; 19 (3): 524528

The authors declare that there are no conflicts of interest present.